TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GERN

Geron Corporation

Healthcare · Biotechnology

1.30$ +0.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Geron Corporation (GERN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 571 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GERN
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
29 26 45 64 114 96 61 118 132 201 221 219 176 180 234 160 100 67 173 149 130 110 185 166 271 226 191 394 594 571
25 24 26 40 35 72 51 112 125 196 217 213 168 118 195 126 98 67 153 116 116 96 166 142 200 187 180 341 491 520
12 4.1 16 7.8 30 19 4.6 13 9.8 97 136 146 109 35 46 16 23 13 43 22 13 17 11 14 9.9 35 57 70 79 79
12 4.1 16 7.8 33 69 47 109 120 190 213 206 163 112 187 121 96 65 152 114 115 95 164 139 196 184 173 334 407 360
0.9 0.5 0.7 1.2 1.5 1.1 1.2 1.7 2.3 1.3 0.8 0.9 1.3 1.8 1.4 0.8 0.6 1.0 1.2 0.5 0.4 1.2 0.8 0.7 1.8 3.1 1.7 39 39
0.5 -1.3 -1.8 0.0 -0.8 0.0 -1.0 -1.2 -0.5 -0.4 -1.2 -0.8 -0.7 -1.4 -3.1 0.0 39 117
3.7 3.6 2.4 1.7 2.1 2.8 2.5 4.1 4.4 3.9 3.1 1.2 1.0 0.1 0.2 0.2 0.2 0.1 0.1 0.4 0.7 0.7 0.8
0.0 0.0 0.0 0.0 0.0 0.0 0.0
15 12 9.5 6.7 3.8 1.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0
5.2 5.0 12 38 50 35 31 12 9.8 11 47 13 7.8 7.8 41 13 14 7.6 42 6.6 7.9 6.5 7.6 30 60 100 111 146 313 345
3.6 3.7 3.6 7.9 8.1 10 9.4 9.8 8.5 9.3 47 13 7.7 7.5 41 13 14 7.6 42 6.6 7.9 6.5 7.6 28 31 46 77 108 88 112
1.2 1.0 0.9 1.2 0.9 0.8 5.5 5.0 2.6 0.1 5.2 6.7 3.6 3.7 8.8 0.4 5.8 0.4 0.9 0.9 22 48 1.0 19
0.8 0.7 1.2 1.3 1.5 1.3 1.6 1.3 2.5 1.9 2.0 2.9 2.4 2.2 3.5 3.0 3.4 1.4 1.0 0.2 0.2 0.5 1.0 1.2 6.9 6.7 10 6.2 8.6 11
42 23 21 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24 50 30 35 118 120
24 21 33 26 64 62 30 106 122 191 174 206 168 173 193 147 86 60 131 142 122 104 178 135 211 126 80 248 280 226
-37 -46 -58 -104 -150 -192 -226 -256 -336 -370 -399 -445 -507 -577 -689 -786 -854 -893 -928 -928 -958 -986 -1,011 -1,080 -1,156 -1,272 -1,414 -1,598 -1,772 -1,856
7.7 11 11 15 21 22 25 31 45 58 66 74 78 88 98 125 127 128 154 163 159 159 177 190 271 328 381 571 646 667

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?